GlaxoSmithKline was involved in study design and data collection for the ECLIPSE, GenKOLS (Norway), and ICGN studies. No other study sponsors had a role in study design or data collection, and none of the study sponsors had a role in data analysis, data interpretation, or writing of the report. The corresponding author had full access to all of the data and the final responsibility to submit for publication.
